These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1398255)

  • 21. Cytokines in cytotherapy.
    Saenger Y; Wolchok J
    Cytotherapy; 2006; 8(4):313-4. PubMed ID: 16923605
    [No Abstract]   [Full Text] [Related]  

  • 22. Potential adverse events with biologic response modifiers.
    Kong JS; Teuber SS; Gershwin ME
    Autoimmun Rev; 2006 Aug; 5(7):471-85. PubMed ID: 16920574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1992; 13():175-90. PubMed ID: 1389909
    [No Abstract]   [Full Text] [Related]  

  • 24. Biological response modifiers in cancer therapy.
    Gupta S; Kanodia AK
    Natl Med J India; 2002; 15(4):202-7. PubMed ID: 12296474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth factors in the management of adult acute leukemia.
    Bernstein SH
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):255-74. PubMed ID: 8449861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment with growth factors and cytokines in hematological diseases].
    Løkkevik E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2352-3. PubMed ID: 8804216
    [No Abstract]   [Full Text] [Related]  

  • 27. Improved efficacy of doxorubicin by simultaneous treatment with interferon-gamma and interleukin-2.
    Lumsden AJ; Codde JP; Gray BN; van der Meide PH
    In Vivo; 1992; 6(5):553-8. PubMed ID: 1457750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Celgene eyes 'inverse vaccines' in Anokion and Delinia deals.
    Sheridan C
    Nat Biotechnol; 2017 Mar; 35(3):189-190. PubMed ID: 28267723
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pathogenesis and therapy of multiple sclerosis. The role of cytokines].
    Weber F; Rieckmann P
    Nervenarzt; 1995 Feb; 66(2):150-5. PubMed ID: 7715757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of biological response modifiers in oncology].
    Vershinina SF; Potiavina EV
    Vopr Onkol; 2003; 49(2):145-51. PubMed ID: 12785193
    [No Abstract]   [Full Text] [Related]  

  • 31. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1990; 11():235-64. PubMed ID: 2121207
    [No Abstract]   [Full Text] [Related]  

  • 32. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1996; 16():239-73. PubMed ID: 8639384
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disappointments and hopes in tumor therapy with biological response modifiers].
    Tanneberger S
    Z Arztl Fortbild (Jena); 1992 Jun; 86(11):551-8. PubMed ID: 1621399
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunological monitoring and clinical trials of biological response modifiers.
    Urba WJ; Baseler MW
    Cancer Chemother Biol Response Modif; 1988; 10():473-91. PubMed ID: 2484322
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytokines alone for PBPC collection in patients with advanced gynaecological malignancies: G-CSF vs G-CSF plus EPO.
    Perillo A; Ferrandina G; Pierelli L; Rutella S; Mancuso S; Scambia G
    Bone Marrow Transplant; 2004 Oct; 34(8):743-4. PubMed ID: 15334047
    [No Abstract]   [Full Text] [Related]  

  • 36. Biological response modifiers: preclinical and clinical results.
    Talmadge JE; Clark J
    Cancer Chemother Biol Response Modif; 1987; 9():454-72. PubMed ID: 3079413
    [No Abstract]   [Full Text] [Related]  

  • 37. Ex vivo and in vivo characterization of biological response modifiers (BRMs).
    Masihi KN; Talmadge JE
    Dev Biol Stand; 1992; 77():143-5. PubMed ID: 1426655
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy by biological response modifiers].
    Urushizaki I
    Rinsho Ketsueki; 1989 Aug; 30(8):1230-2. PubMed ID: 2689681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1993; 14():207-26. PubMed ID: 8312103
    [No Abstract]   [Full Text] [Related]  

  • 40. Biological response modifiers: their possibilities for cancer treatment.
    Franz G
    Verh K Acad Geneeskd Belg; 1989; 51(2):177-85; discussion 186-7. PubMed ID: 2800688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.